Literature DB >> 11096737

Vascular Cognitive Impairment.

.   

Abstract

Although vascular dementia remains the only form of dementia that is preventable, available treatment is limited to the primary and secondary prevention of cerebrovascular disease. Strokes are highly responsive to different forms of prevention and treatment. The effectiveness of the same measures in the prevention of vascular dementia remains unclear, however, owing mainly to the lack of agreement on the definition and management of cognitive impairment. The successful treatment of "vascular dementia" involves the recognition of this term as obsolete, for it falsely implies that the underlying cognitive impairment has an unknown degenerative cause, is progressive, and responds neither to currently available preventive measures nor to treatments. Although dementia resulting from multiple strokes can be a terminal manifestation of this form of cognitive impairment, most patients have treatable cerebrovascular disease. A rational therapeutic approach to the treatment of this cognitive syndrome necessitates an understanding of its broad clinical spectrum and the diverse causes that may be responsive to currently available treatments, from the clinical asymptomatic "brain-at-risk" stage to full-blown dementia.

Entities:  

Year:  2000        PMID: 11096737     DOI: 10.1007/s11940-000-0024-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  31 in total

1.  Leuko-araiosis: an ancient term for a new problem.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

2.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

3.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

4.  Clinical aspects of Alzheimer's disease in black and white patients.

Authors:  R Hargrave; M Stoeklin; M Haan; B Reed
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 6.  Free radicals and brain damage.

Authors:  B K Siesjö; C D Agardh; F Bengtsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1989

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type.

Authors:  T Ohkura; K Isse; K Akazawa; M Hamamoto; Y Yaoi; N Hagino
Journal:  Endocr J       Date:  1994-08       Impact factor: 2.349

Review 9.  Mechanisms of excitotoxicity in neurologic diseases.

Authors:  M F Beal
Journal:  FASEB J       Date:  1992-12       Impact factor: 5.191

10.  Cognitive impairment and risk of stroke in the older population.

Authors:  L Ferrucci; J M Guralnik; M E Salive; M Pahor; M C Corti; A Baroni; R J Havlik
Journal:  J Am Geriatr Soc       Date:  1996-03       Impact factor: 5.562

View more
  3 in total

1.  Treatment of vascular dementia: evidence from epidemiologic studies.

Authors:  Hee-Joon Bae; Dilip K Pandey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

2.  The profile of behavioral and psychological symptoms in vascular cognitive impairment with and without dementia.

Authors:  Meena Gupta; Abhijit Dasgupta; Geeta Anjum Khwaja; Debashish Chowdhury; Yogesh Patidar; Amit Batra
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

3.  The Standardization of the Clock Drawing Test (CDT) for People with Stroke Using Rasch Analysis.

Authors:  Doo Han Yoo; Deok Gi Hong; Jae Shin Lee
Journal:  J Phys Ther Sci       Date:  2014-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.